Today’s stock pick update

Learn More From "Fail" to Fortune in 18 months (See How) Imagine if you mastered a simple way that allowed you to turn market uncertainty into an absolute fortune in just 18 months. Click here, and find out specifically what one investor did to retire in 18 months with $2.4 Million. [ad] And Ed’s story where he turned $5,000 into $15 Million (and you’ll learn his secret). Microsoft Is Buying Nuance For $19.6 Billion In Massive Bet On Healthcare AI Technology

Microsoft is buying Nuance Communications for $19.6 billion, making a huge bet on health-care artificial intelligence. The software giant announced it will pay $56 per share for Nuance in an all-cash deal, and marks Microsoft’s largest acquisition since LinkedIn. Microsoft CEO Satya Nadella said in a t... Read More

Affimed N.V. (NASDAQ: AFMD): Affimed announced today pre-clinical data on its Innate Cell Engager (ICE) AFM24 as mono therapy and in combination with adoptively transferred NK cells. “AFM24’s novel mechanism of action is independent of EGFR signaling and has the potential to change the treatment paradigm for EGFR-expressing solid tumors,” Read More

WBA is up 63% since its bear market low – is there anything left? Long-term demographic trends are generally favorable for pharmacies, even outside the scope of the pandemic. Continued aging of the Baby Boomer generation, and with Generation X following not far behind in the next decade or two, means that demand for prescription drugs is expected to only increase. When you add in other fundamental factors like WBA’s long-standing status as a dividend aristocrat (members of the S&P 500 Index that have paid a dividend for 25 consecutive years or more) a... Read More

Your Featured Stock PLx Pharma Inc. (PLXP) – Buy Price: $10.00 or better PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company’s lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system, which provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable, and predictable pl... Read More

Other Top Stories GM's Cruise to operate all-electric driverless cars in Dubai Rome judge orders arrest of Vatican suspect in London deal Tensions rise in water battle along Oregon-California line How billionaire is using financial muscle for racial equity Tweaked COVID vaccines in testing aim to fend off variants

Trend Following Picks PLx Pharma Inc. (PLXP) – Buy Price: $10.00 or better GrowGeneration Corp. (GRWG) – Buy Price: $59.00 or better Williams-Sonoma, Inc. (WSM) – Buy Price: $188.00 or better L Brands, Inc. (LB) – Buy Price: $66.00 or better Kopin Corporation (KOPN) – Buy Price: $11.50 or better All Picks

Reversal Picks HEXO Corp. (HEXO) Buy Target $7.67 Sell Target $8.95 Birks Group Inc. (BGI) Buy Target $3.59 Sell Target $4.29 Barnwell Industries, Inc. (BRN) Buy Target $3.23 Sell Target $3.74 Yamana Gold Inc. (AUY) Buy Target $4.79 Sell Target $5.29 Peabody Energy Corporation (BTU) Buy Target $3.64 Sell Target $4.27 All Picks

Low Price Stock Picks Blonder Tongue Laboratories, Inc. (BDR) Ballantyne Strong, Inc (BTN) LightInTheBox Holding Co., Ltd. (LITB) Northern Dynasty Minerals Ltd. (NAK) Protalix BioTherapeutics, Inc. (PLX) All Picks

Already subscribed to our premium service? Click here to Login. Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

 

This email was sent to phanhoa1821960.trader@blogger.com  from Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037  Unsubscribe  Disclaimers, Terms & Conditions | Privacy Policy Copyright 2020  Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.